Jia Jie Debt
| 4109 Stock | TWD 24.30 0.15 0.61% |
Jia Jie Biomedical has over 190.33 Million in debt which may indicate that it relies heavily on debt financing. . Jia Jie's financial risk is the risk to Jia Jie stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Jia Jie's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Jia Jie's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Jia Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Jia Jie's stakeholders.
For most companies, including Jia Jie, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Jia Jie Biomedical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Jia Jie's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Jia Jie's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Jia Jie is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Jia Jie to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Jia Jie is said to be less leveraged. If creditors hold a majority of Jia Jie's assets, the Company is said to be highly leveraged.
Jia |
Jia Jie Biomedical Debt to Cash Allocation
Many companies such as Jia Jie, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Jia Jie Biomedical has accumulated 190.33 M in total debt with debt to equity ratio (D/E) of 27.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Jia Jie Biomedical has a current ratio of 1.8, which is within standard range for the sector. Debt can assist Jia Jie until it has trouble settling it off, either with new capital or with free cash flow. So, Jia Jie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Jia Jie Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Jia to invest in growth at high rates of return. When we think about Jia Jie's use of debt, we should always consider it together with cash and equity.Jia Jie Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Jia Jie's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Jia Jie, which in turn will lower the firm's financial flexibility.Jia Jie Corporate Bonds Issued
Understaning Jia Jie Use of Financial Leverage
Understanding the structure of Jia Jie's debt obligations provides insight if it is worth investing in it. Financial leverage can amplify the potential profits to Jia Jie's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its cost of debt.
Jia Jie Biomedical Co., Ltd. provides natural terrapin related nutrition supplements in Taiwan, Japan, and Mainland China. Jia Jie Biomedical Co., Ltd. was founded in 1995 and is based in Kaohsiung, Taiwan. MURAD CHIA is traded on Taiwan OTC Exchange in Taiwan. Please read more on our technical analysis page.
Pair Trading with Jia Jie
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jia Jie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jia Jie will appreciate offsetting losses from the drop in the long position's value.Moving together with Jia Stock
Moving against Jia Stock
| 0.89 | 2881A | Fubon Financial Holding | PairCorr |
| 0.87 | 2891 | CTBC Financial Holding | PairCorr |
| 0.86 | 2882B | Cathay Financial Holding | PairCorr |
| 0.84 | 1231 | Lian Hwa Foods | PairCorr |
| 0.75 | 2603 | Evergreen Marine Corp | PairCorr |
The ability to find closely correlated positions to Jia Jie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jia Jie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jia Jie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jia Jie Biomedical to buy it.
The correlation of Jia Jie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jia Jie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jia Jie Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jia Jie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Jia Stock Analysis
When running Jia Jie's price analysis, check to measure Jia Jie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jia Jie is operating at the current time. Most of Jia Jie's value examination focuses on studying past and present price action to predict the probability of Jia Jie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jia Jie's price. Additionally, you may evaluate how the addition of Jia Jie to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.